
Claims of Misconduct Mar MDMA Research for PTSD
Clinical trials investigating the psychedelic MDMA as a treatment for PTSD are facing claims of research challenges and allegations of misconduct that could mar the results of the research.

Clinical trials investigating the psychedelic MDMA as a treatment for PTSD are facing claims of research challenges and allegations of misconduct that could mar the results of the research.

A study cohort will examine the efficacy of psilocybin for the treatment of issues like PTSD and addiction.

Psychedelic therapy could be coming to Atlanta.

Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD.

Clinical trials investigating the psychedelic MDMA as a treatment for PTSD are facing claims of research challenges and allegations of misconduct that could mar the results of the research.

A study cohort will examine the efficacy of psilocybin for the treatment of issues like PTSD and addiction.

Psychedelic therapy could be coming to Atlanta.

Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD.
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!
